![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, August 29, 2017 8:48:34 PM
None
One World Cannabis
Developing and Commercializing Cannabis-based Treatments
One World Cannabis Ltd, a wholly owned Israeli subsidiary of OWC Pharmaceutical Research Corp. (OTCQB:OWCP), is focused on discovering, developing, and commercializing cannabis-based novel therapeutic products and treatments. Initially, the company is developing treatments for multiple myeloma, psoriasis, fibromyalgia, PTSD (post-traumatic stress disorder), and migraines.
While cannabis has been used as medicine for thousands of years, there is minimal clinical data supporting its medical benefits. One World Cannabis is proceeding with clinical trials to create scientifically sound cannabis medicines for various medical conditions. One World Cannabis intends to investigate specific cannabis strains, combinations of the cannabinoids THC and CBD, and optimal dosages.
The company’s first clinical trials explore potential treatments for fibromyalgia, psoriasis/basal cell carcinoma, post-traumatic stress disorder (PTSD), and seizures. The second set of clinical trials, which have not yet begun and are not yet funded, are anticipated to focus on the development of cannabis medicines for Crohn’s disease, Parkinson’s disease, Tourette’s syndrome, migraines, chronic pain, Alzheimer’s disease, pediatric epilepsy, prostate cancer, and diabetes.
FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM